← Scoopfeeds — Intelligent news, curated.
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
business

Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug

MarketWatch · Jun 8, 2026, 10:16 AM · Also reported by 1 other source

Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

Read full story on MarketWatch → More top stories

Also covered by

CNBC Weight loss drug maker sinks 25% after new safety data spooks investors

More in business

CoinDesk
Crypto's recovery remains unsecure as SpaceX, Anthropic IPOs loom. Stronger ETF inflows would help.
Yahoo Finance
IASB’s Global Preparers Forum appoints new member
CNBC
Marvell Technology jumps almost 9% in premarket after news it will join the S&P 500 index
Yahoo Finance
Spacecraft developer Quantum Space to go public in $1.2 billion SPAC deal
CNBC
USAA to return nearly $1 billion to Florida members as legal reforms help lower insurance costs
Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop